Updates on Endoscopic Stenting for Unresectable Malignant Hilar Biliary Obstruction

Area of Science:

• Gastroenterology and Hepatology
• Interventional Endoscopy
• Oncology

Background:

• Malignant hilar biliary obstruction (MHBO) leads to jaundice and cholangitis, requiring biliary drainage.
• Endoscopic biliary stenting is the primary treatment for unresectable MHBO due to its minimally invasive approach.
• The complex anatomy of the hilar bile ducts presents significant challenges for stenting procedures.

Purpose of the Study:

• To review the current evidence, challenges, and future directions for endoscopic stenting in MHBO.
• To address the complexities of stenting in the hilar region, especially for unresectable tumors.
• To provide insights into evolving stenting strategies influenced by advances in antitumor therapies.

Main Methods:

• Comprehensive literature review of endoscopic stenting techniques for malignant hilar biliary obstruction.
• Analysis of current treatment strategies and their efficacy in managing complex hilar strictures.
• Evaluation of challenges associated with hilar biliary stenting and potential solutions.

Main Results:

• Endoscopic stenting remains the first-line treatment for MHBO, offering a minimally invasive option.
• Hilar region anatomy poses unique difficulties, necessitating specialized techniques and approaches.
• Antitumor therapy advancements impact the context and development of stenting strategies.

Conclusions:

• MHBO stenting is technically challenging, and established treatment strategies are still evolving.
• A thorough understanding of current evidence is crucial for optimizing patient outcomes.
• Further research is needed to refine techniques and develop evidence-based guidelines for MHBO stenting.